Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05907707 · ClinicalTrials.gov registry record · NA
Effects of Gamma-tACS on Memory and Sleep
A NA study, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 11
- Enrollment target
NCT05907707 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 11 participants.
The verdict
NCT05907707, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
Study Summary
The purpose of this clinical trial is to investigate the feasibility and efficacy of non-invasive transcranial alternating current stimulation (tACS) at gamma frequency in enhancing memory recall and modulating sleep network dynamics measured by at-home electroencephalography (EEG) in healthy elderly people. Eligible participants will first collect sleep EEG at home for one night to acclimate to the data collection during sleep. Participants are then randomized into first undergoing either tACS at gamma band frequencies (i.e. 40Hz) or tACS at a control frequency (i.e. 21Hz). Stimulation is administered in the lab during a cognitive testing battery that includes memorizing items. After a night of sleep with EEG at home, participants return to the lab the following day to measure memory recall. Recall is performed again after five days. This sequence of encoding during stimulation in the lab, sleep EEG at home for one night, and recall is then repeated for the other stimulation condition about a week later. Participants are wearing an actigraphy wristband throughout the study period.
Interventions
- DEVICE Gamma transcranial alternating current stimulation
- DEVICE Control transcranial alternating current stimulation
- DEVICE EEG headband
- DEVICE Actigraphy wristband
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2023-06-28 |
| Est. Completion | 2023-12-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05907707
The ClinicalTrials.gov registry entry for NCT05907707 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Gamma transcranial alternating current stimulation is the first listed.
NCT05907707 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05907707 about?
NCT05907707 is a clinical study titled "Effects of Gamma-tACS on Memory and Sleep". The purpose of this clinical trial is to investigate the feasibility and efficacy of non-invasive transcranial alternating current stimulation (tACS) at gamma frequency in enhancing memory recall and modulating sleep network dynamics measured by at-home electroencephalography (EEG) in healthy elderl...
What is the current status of trial NCT05907707?
This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2023-06-28. Estimated completion is 2023-12-28.
What interventions are being tested in trial NCT05907707?
The interventions under investigation include: Gamma transcranial alternating current stimulation (DEVICE), Control transcranial alternating current stimulation (DEVICE), EEG headband (DEVICE), Actigraphy wristband (DEVICE).
Who is sponsoring clinical trial NCT05907707?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.